Medifast, Inc. (MED) Misses Q4 EPS by 13c; Issues Mixed Guidance
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $11.44 +3.62%
Revenue Growth %: -29.3%
Financial Fact:
Nonoperating Income (Expense), Total: 58K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -29.3%
Financial Fact:
Nonoperating Income (Expense), Total: 58K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q4 EPS of $0.08, $0.13 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $69 million versus the consensus estimate of $70.97 million.
Medifast, Inc. sees Q1 2012 EPS of $0.36-$0.38, versus the consensus of $0.45. Medifast, Inc. sees Q1 2012 revenue of $86.5-$88.5 million, versus the consensus of $83.4 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
Medifast, Inc. sees Q1 2012 EPS of $0.36-$0.38, versus the consensus of $0.45. Medifast, Inc. sees Q1 2012 revenue of $86.5-$88.5 million, versus the consensus of $83.4 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Accenture downgraded by TD Cowen on AI concerns
- Playboy to buy back 16.6M shares from Fortress at $1.05 each
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
